21
Participants
Start Date
July 6, 2018
Primary Completion Date
January 30, 2021
Study Completion Date
December 30, 2024
RheOx
RheOx is a device-based, energy delivery system that delivers energy to ablate soft tissue such as the airway epithelium and sub-mucosal tissue layers. The energy is delivered via a proprietary catheter through the bronchoscope.
University of Pittsburgh Medical Center, Pittsburgh
Temple University School of Medicine, Philadelphia
MedStar Health, Baltimore
Mayo Clinic Florida, Jacksonville
University of Alabama Lung Health Center, Birmingham
University of Iowa, Iowa City
University of Chicago, Chicago
Beth Israel Deaconess, Boston
Lead Sponsor
Gala Therapeutics, Inc.
INDUSTRY